Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01393457 · ClinicalTrials.gov registry record · Phase 2
Cognitive Remediation for Cocaine Dependence
A Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 2
- Development phase
- 119
- Enrollment target
NCT01393457: Completed Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
NCT01393457 is a Phase 2 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 119 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (11% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01393457, a Phase 2 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 119 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate treatments designed to improve cocaine treatment success by combining medications that target cocaine-related cognitive impairments.
Primary Outcome
The mean of the predicted probabilities (derived from generalized linear mixed models) of negative drug screens over all 10 weeks is reported, as per the analysis proposed in the protocol.
Interventions
- DRUG Placebo
- DRUG levodopa/carbidopa
- DRUG Ropinirole 2 mg/d
- DRUG Ropinirole 4 mg/d
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2011-06 |
| Est. Completion | 2017-02 |
| Phase | Phase 2 |
What the finished NCT01393457 record still lists
NCT01393457 is an interventional study that assigns participants to a tested intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (11% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT01393457 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01393457 about?
NCT01393457 is a clinical study titled "Cognitive Remediation for Cocaine Dependence". The purpose of this study is to evaluate treatments designed to improve cocaine treatment success by combining medications that target cocaine-related cognitive impairments.
What is the current status of trial NCT01393457?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 119 participants. The study started on 2011-06. Estimated completion is 2017-02.
What interventions are being tested in trial NCT01393457?
The interventions under investigation include: Placebo (DRUG), levodopa/carbidopa (DRUG), Ropinirole 2 mg/d (DRUG), Ropinirole 4 mg/d (DRUG).
Who is sponsoring clinical trial NCT01393457?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01393457's enrollment target sits among peer trials
119 618th of 2000 higher than 1,383 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia